The PCSK9 inhibitors market is estimated to be valued at USD 2.84 Bn in 2026 and is expected to reach USD 8.22 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.4% from 2026 to 2033. https://hallbook.com.br/blogs/906700/PCSK9-Inhibitors-Market-Size-and-Growth-Driven-by-Innovative-Therapeutics